CellDerma: Rethinking Skin Health

A Barrier-First Philosophy

In a saturated cosmeceutical market, what truly makes CellDerma
different?
Most brands are built around results-first thinking – target the pigment, dry the acne, stimulate collagen. It sounds logical, but it overlooks the one system that governs them all: inflammation.

At CellDerma, we take a barrier-first approach. Because when you reduce inflammation, whether visible or silent, you create the biological conditions for healthier skin, regardless of the condition.

Acne, rosacea, eczema, sensitivity… they all share one common pathway: inflammation. Control that, and everything improves.

You mentioned “silent inflammation.” What does that mean in practice?
This is where the industry often misses the mark. Just because skin looks calm doesn’t mean it is. Many patients are using products they believe they “tolerate,” yet these may still be driving low-grade, chronic inflammation at a cellular level.

Over time, this undermines barrier function, accelerates ageing, and perpetuates skin dysfunction. The uncomfortable truth? A product doesn’t need to sting to be harmful.

How does this compare to more traditional ‘active-led’ formulations?
Let’s take a well-known 20% L-ascorbic acid serum often positioned as a gold standard. On paper, it’s impressive. High-strength vitamin C for antioxidant protection and collagen stimulation.

But look deeper at the formulation: high concentrations of L-ascorbic acid, sodium metabisulphite (an established potential allergen), alcohol denat., solubilising systems, and pH-adjusting acids to stabilise the formula.
This creates three key issues:

1. Irritation potential – 20% L-ascorbic acid at low pH is inherently pro-inflammatory for many skin types.
2. Instability – rapid oxidation reduces efficacy and can generate free radicals.
3. Barrier compromise – repeated exposure to low pH and solvent systems can weaken the skin over time.
   So, while the intention is results, the reality can be compromised skin health.

So how does CellDerma approach formulation differently?

We start with the question: What does the skin need to function optimally? Not just to look better temporarily – but to be healthier.

Our formulations are built around four core pillars:

• Honesty – no ingredient theatre or marketing-led decisions.

• Simplicity – purposeful formulations, no unnecessary complexity.

• Efficacy – clinically meaningful outcomes, not just trends.

• Tolerability – truly universal, even for compromised skin.

We prioritise barrier-supportive lipids, anti-inflammatory signalling, and bioactive molecules that work with the skin, not against it.

Retinoids are often seen as effective but irritating. Where does CellDerma stand?
Retinoids are a perfect example of where the industry has accepted compromise. Patients are often told to “push through irritation”, or worse, avoid them entirely if they have rosacea or sensitive skin. We challenged that.

Our retinoid uses a 4th-generation molecule that binds directly to retinoid receptors without the conversion steps that weaken other retinoids like retinol. More importantly, our formulation is designed to support the barrier, not disrupt it.

The result? In two independent clinical studies, all measured parameters – including acne lesion count, pore size, elasticity, hydration, and pigmentation – showed statistically significant improvement at just 4 weeks. And critically, this was achieved with zero cases of side effects, even in sensitive skin types.